Health In Tech Stock Technical Analysis
| HIT Stock | 1.19 0.03 2.59% |
As of the 1st of February, Health In retains the market risk adjusted performance of (1.10), and Risk Adjusted Performance of (0.09). Health In technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Health In Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Health, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HealthHealth In's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is there potential for Insurance Brokers market expansion? Will Health introduce new products? Factors like these will boost the valuation of Health In. Market participants price Health higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Health In listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.103 | Earnings Share 0.02 | Revenue Per Share | Quarterly Revenue Growth 0.904 | Return On Assets |
Health In Tech's market price often diverges from its book value, the accounting figure shown on Health's balance sheet. Smart investors calculate Health In's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Health In's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Health In's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health In is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Health In's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Health In 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Health In's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Health In.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in Health In on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Health In Tech or generate 0.0% return on investment in Health In over 90 days. Health In is related to or competes with Expensify, Viant Technology, TROOPS, X3 Holdings, Teads BV, Robot Consulting, and Silvaco Group. Hitachi, Ltd. manufactures and sells electronic and electrical solutions primarily in Asia, North America, and Europe. More
Health In Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Health In's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Health In Tech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 35.26 | |||
| Value At Risk | (14.21) | |||
| Potential Upside | 11.2 |
Health In Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Health In's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Health In's standard deviation. In reality, there are many statistical measures that can use Health In historical prices to predict the future Health In's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.11) | |||
| Total Risk Alpha | (1.44) | |||
| Treynor Ratio | (1.11) |
Health In February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (1.10) | |||
| Mean Deviation | 5.56 | |||
| Coefficient Of Variation | (719.22) | |||
| Standard Deviation | 7.65 | |||
| Variance | 58.47 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (1.11) | |||
| Total Risk Alpha | (1.44) | |||
| Treynor Ratio | (1.11) | |||
| Maximum Drawdown | 35.26 | |||
| Value At Risk | (14.21) | |||
| Potential Upside | 11.2 | |||
| Skewness | (0.20) | |||
| Kurtosis | 1.99 |
Health In Tech Backtested Returns
Health In Tech holds Efficiency (Sharpe) Ratio of -0.13, which attests that the entity had a -0.13 % return per unit of standard deviation over the last 3 months. Health In Tech exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Health In's market risk adjusted performance of (1.10), and Risk Adjusted Performance of (0.09) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.96, which attests to possible diversification benefits within a given portfolio. Health In returns are very sensitive to returns on the market. As the market goes up or down, Health In is expected to follow. At this point, Health In Tech has a negative expected return of -1.0%. Please make sure to check out Health In's rate of daily change, period momentum indicator, as well as the relationship between the potential upside and jensen alpha , to decide if Health In Tech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.21 |
Weak predictability
Health In Tech has weak predictability. Overlapping area represents the amount of predictability between Health In time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Health In Tech price movement. The serial correlation of 0.21 indicates that over 21.0% of current Health In price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.21 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Health In technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Health In Tech Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Health In Tech volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Health In Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Health In Tech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Health In Tech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Health In Tech price pattern first instead of the macroeconomic environment surrounding Health In Tech. By analyzing Health In's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Health In's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Health In specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 74.65 | 40.21 | 46.24 | 64.78 | PTB Ratio | 45.26 | 27.29 | 31.38 | 29.81 |
Health In February 1, 2026 Technical Indicators
Most technical analysis of Health help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Health from various momentum indicators to cycle indicators. When you analyze Health charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (1.10) | |||
| Mean Deviation | 5.56 | |||
| Coefficient Of Variation | (719.22) | |||
| Standard Deviation | 7.65 | |||
| Variance | 58.47 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (1.11) | |||
| Total Risk Alpha | (1.44) | |||
| Treynor Ratio | (1.11) | |||
| Maximum Drawdown | 35.26 | |||
| Value At Risk | (14.21) | |||
| Potential Upside | 11.2 | |||
| Skewness | (0.20) | |||
| Kurtosis | 1.99 |
Health In February 1, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Health stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.07 | ||
| Daily Balance Of Power | 0.33 | ||
| Rate Of Daily Change | 1.03 | ||
| Day Median Price | 1.23 | ||
| Day Typical Price | 1.22 | ||
| Price Action Indicator | (0.03) | ||
| Market Facilitation Index | 0.09 |
Additional Tools for Health Stock Analysis
When running Health In's price analysis, check to measure Health In's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health In is operating at the current time. Most of Health In's value examination focuses on studying past and present price action to predict the probability of Health In's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health In's price. Additionally, you may evaluate how the addition of Health In to your portfolios can decrease your overall portfolio volatility.